Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

The proline-rich acidic protein is epigenetically regulated and inhibits growth of cancer cell lines.

Zhang J, Wong H, Ramanan S, Cheong D, Leong A, Hooi SC.

Cancer Res. 2003 Oct 15;63(20):6658-65.

PMID:
14583459
[PubMed - indexed for MEDLINE]
Free Article
2.

DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells.

Bommer GT, Jäger C, Dürr EM, Baehs S, Eichhorst ST, Brabletz T, Hu G, Fröhlich T, Arnold G, Kress DC, Göke B, Fearon ER, Kolligs FT.

J Biol Chem. 2005 Mar 4;280(9):7962-75. Epub 2004 Nov 24.

PMID:
15563452
[PubMed - indexed for MEDLINE]
Free Article
3.

Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma.

Qiu GH, Xie H, Wheelhouse N, Harrison D, Chen GG, Salto-Tellez M, Lai P, Ross JA, Hooi SC.

J Hepatol. 2007 Apr;46(4):655-63. Epub 2006 Dec 12.

PMID:
17258345
[PubMed - indexed for MEDLINE]
5.

Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.

Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.

Oncogene. 2005 Nov 24;24(53):7946-52.

PMID:
16007117
[PubMed - indexed for MEDLINE]
6.

Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.

Chen J, Xu J, Ying K, Cao G, Hu G, Wang L, Luo C, Lou M, Mao Y, Xie Y, Lu Y.

Gene. 2004 Sep 29;340(1):61-9.

PMID:
15556295
[PubMed - indexed for MEDLINE]
7.

Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis.

Wang T, Xia D, Li N, Wang C, Chen T, Wan T, Chen G, Cao X.

J Biol Chem. 2005 Feb 11;280(6):4374-82. Epub 2004 Nov 29.

PMID:
15569677
[PubMed - indexed for MEDLINE]
Free Article
8.

Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.

Zhang P, Chan DW, Zhu Y, Li JJ, Ng IO, Wan D, Gu J.

Clin Cancer Res. 2006 Nov 15;12(22):6617-25.

PMID:
17121880
[PubMed - indexed for MEDLINE]
Free Article
9.

CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines.

Shao L, Cui Y, Li H, Liu Y, Zhao H, Wang Y, Zhang Y, Ng KM, Han W, Ma D, Tao Q.

Clin Cancer Res. 2007 Oct 1;13(19):5756-62. Erratum in: Clin Cancer Res. 2007 Nov 1;13(21):6543.

PMID:
17908965
[PubMed - indexed for MEDLINE]
Free Article
10.

Regulation of alternative SRC promoter usage in HepG2 hepatocellular carcinoma cells.

Dehm SM, Bonham K.

Gene. 2004 Aug 4;337:141-50.

PMID:
15276210
[PubMed - indexed for MEDLINE]
11.

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

Wolf I, O'Kelly J, Rubinek T, Tong M, Nguyen A, Lin BT, Tai HH, Karlan BY, Koeffler HP.

Cancer Res. 2006 Aug 1;66(15):7818-23.

PMID:
16885386
[PubMed - indexed for MEDLINE]
Free Article
12.

Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells.

Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT.

Cell Physiol Biochem. 2009;24(3-4):253-62. doi: 10.1159/000233250. Epub 2009 Aug 3.

PMID:
19710540
[PubMed - indexed for MEDLINE]
13.

[Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].

Xu JY, Chen LB, Xu JY, Yang Z, Wei HY, Xu RH.

Ai Zheng. 2006 May;25(5):526-32. Chinese.

PMID:
16687068
[PubMed - indexed for MEDLINE]
14.

GADD45gamma, down-regulated in 65% hepatocellular carcinoma (HCC) from 23 chinese patients, inhibits cell growth and induces cell cycle G2/M arrest for hepatoma Hep-G2 cell lines.

Sun L, Gong R, Wan B, Huang X, Wu C, Zhang X, Zhao S, Yu L.

Mol Biol Rep. 2003 Dec;30(4):249-53.

PMID:
14672412
[PubMed - indexed for MEDLINE]
15.

TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.

Jiang C, Pecha J, Hoshino I, Ankrapp D, Xiao H.

Cancer Res. 2007 Apr 15;67(8):3574-82.

PMID:
17440068
[PubMed - indexed for MEDLINE]
Free Article
16.

Overexpression of the signal peptide whirlin isoform 2 is related to disease progression in colorectal cancer patients.

Toiyama Y, Mizoguchi A, Kimura K, Hiro J, Tutsumi T, Inoue Y, Miki C, Kusunoki M.

Int J Oncol. 2009 Oct;35(4):709-15.

PMID:
19724906
[PubMed - indexed for MEDLINE]
17.

Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.

Ushio K, Hashimoto T, Kitamura N, Tanaka T.

Mol Cancer Res. 2009 Jul;7(7):1179-88. doi: 10.1158/1541-7786.MCR-08-0289. Epub 2009 Jun 30.

PMID:
19567783
[PubMed - indexed for MEDLINE]
Free Article
18.

[Mutations of tumor suppressor gene PTEN mutations in hepatocellular carcinoma and its implications in tumor proliferation and apoptosis].

Guo SP, Wang L, Wang WL, Li QL, Wang WY, Zhang J.

Zhonghua Bing Li Xue Za Zhi. 2006 Aug;35(8):467-72. Chinese.

PMID:
17069699
[PubMed - indexed for MEDLINE]
19.

Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.

Feng P, Wang B, Ren EC.

Int J Biochem Cell Biol. 2008;40(1):98-109. Epub 2007 Jul 26.

PMID:
17698398
[PubMed - indexed for MEDLINE]
20.

A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.

Pampalakis G, Prosnikli E, Agalioti T, Vlahou A, Zoumpourlis V, Sotiropoulou G.

Cancer Res. 2009 May 1;69(9):3779-87. doi: 10.1158/0008-5472.CAN-08-1976. Epub 2009 Apr 21.

PMID:
19383923
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk